Judges for the category awards are:

Animal Science, Veterinary Research and Zoology

  • Cheryl London

    The Ohio State University, USA

    Cheryl is currently the Thekla R. and Donald B. Shackelford Professor in Canine Medicine at The Ohio State University, where her research interests include the use of spontaneous tumors in dogs and cats as models for human cancer, and the investigation of kinase dysfunction in animal tumors. She graduated from Tufts School of Veterinary Medicine, and after two years in private practice completed a residency in Medical Oncology at the University of Wisconsin, Madison. Cheryl also has a PhD in Immunology from Harvard University and is a member of the American College of Veterinary Pathology’s task force to evaluate grading of canine mast cell tumors.

     

    Cheryl is a Section Editor for BMC Veterinary Research.


  • Simon More

    University College Dublin, Ireland

    Simon is a Professor of Veterinary Epidemiology and Risk Analysis at University College Dublin. He is also the Director of the Centre for Veterinary Epidemiology and Risk Analysis (CVERA), the national resource centre for veterinary epidemiology in Ireland. CVERA provide epidemiological support for the effective detection, control and eradication of a range of animal health issues in Ireland. Simon works closely with the government and industry in Ireland, and is currently chair of the Johne’s disease and CellCheck working groups at Animal Health Ireland, which is addressing a range of non-regulatory animal health issues in the country. He is also Chair of the Animal Health and Welfare Panel at the European Food Safety Authority, which provides independent scientific advice, primarily to the European Commission.

    Simon is the Deputy Editor of the Irish Veterinary Journal.

     

  • Alex Kacelnik

    University of Oxford, UK

    Alex trained as a zoologist in Argentina, later working in the Zoology and Psychology Departments in Oxford, Groningen and Cambridge. He founded the Behavioural Ecology Research Group at University of Oxford in 1990, where he is also a Fellow of Pembroke College. He studies animal and human behaviour from a multidisciplinary perspective, combining experimental analysis with theoretical modelling. He received the Cogito Prize (jointly with Ernst Fehr) for his interdisciplinary work on risk-related behaviour, and the Research Award of the Society of Comparative Cognition for his life-long contributions to cognitive research. Alex was elected a Fellow of the Royal Society in 2011 and has a strong interest in philosophical and social implications of ethology, and would engage gladly in any unsolvable argument raised in these areas.

    Alex is an Editorial Advisor for BMC Ecology.

Cancer

  • Ian Cree

    Warwick Medical School, UK

    Ian is the Yvonne Carter Professor of Pathology at Warwick Medical School, and also Director of the Efficacy and Mechanism Evaluation programme for the UK National Institute of Health Research Evaluation Trials and Studies Coordinating Centre. He also chairs the Interspeciality committee on Molecular Pathology for the Royal College of Pathologists and sits on the NICE Diagnostics Advisory Committee.

    Trained as a general pathologist with a PhD in immunology, Ian’s research career has been based on investigating disease mechanisms to improve diagnosis and treatment. This has involved him designing, conducting and leading clinical trials as well as a number of large multicentre studies.

    Ian’s current research interests are mostly cancer-related but previous studies have included infectious disease, asthma, and ophthalmology.

    He has published over 200 papers, and two books. For the last 20 years, Ian has been involved in developing predictive methods to allow individualised therapy of cancer. Ian is has recently been involved in the implementation of mutation testing services, including external quality assurance schemes, and intra-operative assessment of breast cancer sentinel nodes.

    Ian is on the Editorial Board of BMC Cancer.

  • Kevin A. Camphausen

    National Institutes of Health, USA

    Kevin received his M.D. from Georgetown University in 1996. He completed his internship at Georgetown in 1997 and a residency in radiation oncology at the Joint Center for Radiation Therapy at Harvard Medical School in 2001. Kevin spent 2 years working in the laboratory of Dr. Judah Folkman studying the interaction of angiogenesis inhibitors and radiotherapy. He joined the NCI in July of 2001 as a tenure track investigator. He served as the Deputy Branch Chief beginning in April of 2004 and was appointed Branch Chief in 2007. He is currently involved in conducting a Phase II trial in patients with Glioblastoma multiforme (GBMs) comparing the patient’s urinary VEGF and MMP-2 levels, as early biomarkers of disease progression, following the completion of radiotherapy, to the clinical parameters that comprise the recursive partition analysis (RPA) of the Radiation Therapy Oncology Group (RTOG), which are currently used to stratify patients and predict progression free survival and overall survival.

    Kevin’s laboratory actively collaborates with groups within the NCI/NIH intramural program including pre-clinical studies with the laboratory of Howard Fine and clinical studies with the NOB and Howard Fine. He also maintains an active collaboration with Marsha Moses at Harvard Medical School.

    Kevin is Deputy Editor of Radiation Oncology.

  • Edith A. Perez

    Mayo Clinic, USA

    Edith is the Deputy Director at Large for Mayo Clinic Cancer Center in Florida, Group Vice Chair of the Alliance for Clinical Trials in Oncology, Director of the Breast Program, and the Serene M. and Frances C. Durling Professor of Medicine at Mayo Medical School. She is a cancer specialist and an internationally known translational researcher at Mayo Clinic. Her roles extend nationally, including positions within Mayo Clinic, the American Association for Cancer Research, the American Society of Clinical Oncology, and the National Cancer Institute.

    She has developed, and is involved in, a wide range of clinical trials exploring the use of new therapeutic agents for the treatment and prevention of breast cancer. She leads and has helped develop basic research studies to evaluate the role of genetic markers in the development and aggressiveness of breast cancer. She has authored more than 550 research articles in journals, books, and abstracts. Edith is invited frequently to lecture at national and international meetings and serves on the editorial boards of multiple academic journals.

    Edith is on the Editorial Board of Breast Cancer Research and the Journal of Hematology and Oncology.

Clinical Medicine

  • Yehuda Shoenfeld

    Tel-Aviv University, Israel

    Yehuda is the founder and head of the Zabludowicz Center for Autoimmune Diseases at the Sheba Medical Center, which is affiliated to the Sackler Faculty of Medicine in Tel-Aviv University, Israel. He is the Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases at the Tel-Aviv University.

    His clinical and scientific works focus on autoimmune and rheumatic diseases, and he has published more than 1700 papers in journals such as New Eng J Med, Nature, Lancet, Proc Nat Acad Scie, J Clin Invest, J Immunol, Blood, FASEB, J Exp Med, Circulation, Cancer and others. His articles have over 31,000 citations. He has written more than three hundred and fifty chapters in books, and has authored and edited 25 books, some of which became cornerstones in science and clinical practice, such as “The Mosaic of Autoimmunity”, “Infections and Autoimmunity” and the textbook “Autoantibodies” and “Diagnostic criteria of autoimmune diseases”, all of which were published by Elsevier and sold by the thousands.

    He is on the editorial board of 43 journals in the field of rheumatology and autoimmunity and is the founder and the editor of the IMAJ (Israel Medical Association Journal) the representative journal of science and medicine in the English language in Israel, and also is the founder and Editor of the “Autoimmunity Reviews” (Elsevier) (Impact factor 6.6) and Co-Editor of “Journal of Autoimmunity” (Impact factor 7.4). For the last twenty years Yehuda has been the Editor of “Harefuah” – The Israel journal in medicine (Hebrew) and he has edited the Israel Medical Encyclopedia (10 volumes, 5000 items). He has organized over 20 international congresses in autoimmunity.

    Yehuda received the EULAR prize in 2005, in Vienna, Austria: “The infectious etiology of anti-phospholipid syndrome,” and received a gold medal from the Slovak Society of Physicians for his contribution to Israel – Slovakia collaboration (March 2006), and is honorary member of the Hungarian Association of Rheumatology. In UC Davis, USA, Yehuda received the Nelson’s Prize for Humanity and Science for 2008. In 2009 he was honored as Doctoris Honoris Causa, from Debrecen University (Hungary), and from 2009 he is honorary member of the Slovenian National Academy of Sciences. He has recently been awarded a Life Contribution Prize in Internal Medicine in Israel, 2012.

    Yehuda has educated a long list of students (>25) being heads of departments and institutes.

    Yehuda is on the Editorial Board of BMC Medicine.

  • Larry Friedman

    Formerly at National Institutes of Health, USA

    Larry was at the National Heart, Lung, and Blood Institute of the National Institutes of Health from 1972 to 2005. During that time, he served as Chief of the Clinical Trials Branch, Director of the Division of Epidemiology and Clinical Applications, and Associate Director for Ethics and Clinical Research. Since his retirement from NIH, he has been an Independent Consultant to several NIH institutes and other organizations, including serving on the National Advisory Council on Aging.

    Larry has been involved in, overseen, consulted on, and been a reviewer for many clinical trials, including serving on safety committees and data monitoring committees. He has written numerous articles, co-authored books, and taught courses on clinical trials.

    Larry is on the Editorial Board of Trials.

  • Khalid Khan

     Barts  and the London School of Medicine, UK

    Khalid Khan graduated from Medical School in 1989. Currently, he is Professor of Women’s Health and Clinical Epidemiology at Barts and the London School of Medicine. His academic expertise is in patient-oriented health research. He has published over 200 peer reviewed journal articles making contribution in systematic reviews (meta-analyses), trials of treatments and tests, health technology assessments, and evaluation of educational methods. His book on Evidence-based Medicine won the BMA medical book competition. He Editor-in-Chief of BJOG: An International Journal of Obstetrics and Gynaecology, and Associate Editor of Evidence-based Medicine.

    Khalid leads the Women’s Health Research Unit which undertakes multidisciplinary research to understand why women and their unborn children can become ill and how they can stay healthy. Clinical trials and systematic reviews conducted collaboratively with patient and the public involvement and with input from a range of disciplines such as clinical epidemiology, biostatistics and health technology assessment are the cornerstones of research that improves policy and practice embedded within communities and health systems locally, nationally and globally. He established the Katherine Twining Network to facilitate multidisciplinary research in reproductive health and childbirth, providing leadership in development and delivery of women’s health studies. It is named after the first Matron and founder of the Plaistow Maternity Hospital (established in 1889 as St Mary’s District Nurses’ Home). Its services are currently delivered through the maternity provision at Newham General Hospital.

    Kalid is Editor-in-Chief for BJOG: An International Journal of Obstetrics and Gynaecology

Computational and high-throughput studies in genomics and systems biology

  • Laurence D. Hurst

    University of Bath, UK

    Laurence is a Professor of Evolutionary Genetics in the Department of Biology and Biochemistry at The University of Bath. He completed his Bachelor of Arts in Zoology at Churchill College, Cambridge in 1987. After a year at Harvard University he returned to the UK, obtaining a D.Phil at the University of Oxford in 1991 under the supervision of W. D. Hamilton and Alan Grafen. He was a Royal Society Research Fellow at the University of Cambridge from 1993 to 1996 and has been a Professor at the University of Bath since 1997. His research interests cover a broad span of evolution, genetics and genomics. His group dominantly use computational and mathematical techniques to understand the way genes and genomes evolve.

    Laurence is an Editorial Board member for a number of BioMed Central journals, including Genome BiologyBMC BiologyBMC Evolutionary BiologyBMC Systems Biology and BMC Proceedings.

  • Pauline Ng

    Genome Institute of Singapore

    Pauline earned her PhD from Fred Hutchinson Cancer Research Center and University of Washington in 2002. She created the SIFT algorithm which predicts the effect of missense changes. She then worked at Illumina for four years, where she designed the SNP panels for GWAS studies. Later she worked at J. Craig Venter Institute, studying one of the first individually sequenced human genomes and assessing next-generation sequencing technology and direct-to-consumer personalized medicine companies. At present she is a Group Leader at Genome Institute of Singapore. The major research focus of Pauline’s group is understanding the relationship between genotype and phenotype. This includes research in personalized medicine, understanding disease mutations, and working with next-generation sequencing technologies and protein sequences.

  • Matteo Pellegrini

    University of California, Los Angeles, USA

    Matteo is a Professor at the Department of Molecular, Cell and Developmental Biology at the UCLA. He earned his doctorate at Stanford in 1996. He joined the UCLA faculty from Merck and Company in 2005. In addition to his affiliation with the Broad Stem Cell Research Center, Matteo is a member of UCLA’s Jonsson Comprehensive Cancer Center, the ACCESS program, the California Nanosystems Institute and the Institute for Genomics and Proteomics. He is also a co-director of the Broad Stem Cell Research Center’s biosequencing core. His research combines statistics, computer science, biology, and genetics to better understand stem cells. Matteo’s group focuses on the development of computational approaches to interpret genomic data that allow them to develop large-scale models of transcriptional and epigenetic regulation.

    Matteo is a Section Editor for BMC Systems Biology and a member of Editorial Board of BMC Research Notes.

Microbiology, Immunology, Infection and Inflammation

  • Persephone Borrow

    The Jenner Institute, University of Oxford, UK

    Persephone is a viral immunologist whose research interests centre on understanding virus-immune system interactions and their roles in determining the balance between virus clearance versus viral persistence and associated pathogenesis. She obtained her BA(MA) and PhD degrees from the University of Cambridge, UK then conducted postdoctoral research at The Scripps Research Institute, USA, before returning to the UK to lead the Viral Immunology Group at the newly-established Edward Jenner Institute for Vaccine Research. She subsequently joined the Nuffield Department of Medicine at the University of Oxford, where she is currently a Reader and a Jenner Institute Investigator. Her current research mainly focuses on analysis of innate and T cell responses in HIV infection, and aims to inform the development of prophylactic and therapeutic strategies based on modulation of these host responses.

    Persephone is on the Editorial Board of Retrovirology.

  • Frank Cox

    London School of Hygiene and Tropical Medicine, UK

    Francis Edmund Gabriel (Frank) Cox is a Senior Research Fellow in the Department of Disease Control in the Faculty of Infectious and Tropical Diseases at the London School of Hygiene and Tropical Medicine. He was previously Professor of Parasite Immunology at King’s College London. His research interests are focussed on the cellular aspects of the immunology of malaria and oriental sore. He has published over 100 original papers, reviews and book chapters in these fields and has edited or co-edited a number of books including Infection and Immunity (with D H Davies, M A Halablab, J. Clarke and TW K Young) and Immunology of Intracellular Parasitism (with F Y Liew). He has edited the journals Parasitology Today (now Trends in Parasitology), Parasitology and the Transactions of the Royal Society of Tropical Medicine and Hygiene and serves on a number of editorial boards. He is also the external expert on infectious diseases on the Open University‘s Life and Biomolecular Sciences Research Management Committee. His other interests include the history of parasitology and tropical medicine and he edited the Wellcome Trust Illustrated History of Tropical Diseases and the Royal Society of Tropical Medicine and Hygiene’s Interactive CD, Six Thousand Years of Tropical Medicine, and has published a number of papers in this field.

    Frank is an Editorial Board Member for Parasites & Vectors.

  • Susanna Esposito

    University of Milan, Italy

    Susanna is the Director of the Paediatric Clinic 1 and the Paediatric Infectious Diseases Unit at the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico in Milan, Italy, where she is also Chief of the outpatient clinic for travel medicine and head of the Lompardy Region’s Lyme Disease Centre. She is also Chief of one of the paediatric HIV clinics in the Regione Lombardia, coordinator of the Epidermolysis Bullosa Centre and an Associate Professor in paediatrics at the Department of Maternal and Paediatric Sciences, Università degli Studi di Milano, Milan, Italy. Susanna is currently President of the Italian Society of Paediatric Infectious Diseases; she is also a member of the Steering committee on vaccines of the Italian Society of Paediatrics and the Italian Society of Allergy and Immunology, President of the WHO Committee for measles and rubella eradication, and serves on the secretariat of the steering committee of the Italian Society of Preventive and Social Paediatrics. She has been a member of the Steering Committee of the European Society of Paediatric Infectious Diseases (ESPID) (2004-2007) and a member of the Committees for Training and Research of ESPID since 2007. Susanna’s research has focused on respiratory tract infections, vaccines and preventive paediatrics, antibiotic therapy and emerging infections. Her research activities has led to the publication of more than 200 articles in international journals reported by PubMed with an overall impact factor >1,000 and h-index >30. She has won several postgraduate awards and served on the Editorial Boards of various journals including The Paediatric Infectious Disease Journal (since 2005) and Human Vaccines (since 2010).

    Susanna is a Section Editor for BMC Infectious Diseases.

Molecular and Cellular Science

  • Wallace Marshall

    University of California, San Francisco (UCSF), USA

    After his undergraduate training at Stony Brook in Electrical Engineering and Biochemistry, Wallace studied for his PhD with John Sedat at University of California, San Francisco (UCSF) and completed his postdoctoral work with Joel Rosenbaum at Yale. Wallace then returned to UCSF where today his laboratory is interested in the engineering design principles that underlay cellular morphogenesis. His research is particularly focussed on how cells control the size, number, and position of organelles using a combination of genomic, proteomic, imaging, and mathematical modeling approaches. Work in his laboratory makes use of yeast, Chlamydomonas reinhardtii and Stentor coeruleus, always seeking the simplest possible model system in which to study a particular type of geometry problem.

     

    Wallace is an Editorial Board Member for Cilia.

     

  • John Rossi

    Beckman Research Institute,City of Hope, California, USA

    John received his doctorate in microbial genetics from the University of Connecticut in Storrs. For his postdoctoral training he went to Brown University Medical School in Providence, Rhode Island where he trained under Dr. Arthur Landy studying the genomic structure, organization and expression of two gene clusters encoding tRNA-tyrosine in E. coli. In 1980 John moved to the Department of Molecular Genetics at the City of Hope in Duarte, California. His laboratory there began to develop and test the idea of utilizing catalytic RNAs or ribozymes for inhibition of HIV infection. This research program has led to two clinical trials in which ribozyme genes have been transduced into hematopoietic stem cells for autologous transplant in HIV infected individuals. Work in the laboratory continues to focus upon enhancing the intracellular efficacy of ribozymes and RNA decoys via RNA trafficking and target co-localization approaches. This program has led to a first of its kind hematopoietic stem cell clinical trial using a triple gene therapy approach in AIDS/lymphoma patients. At present a large percentage of the research effort of the lab is focused upon the biology and utilization of small interfering RNAs, or siRNA and the evolution of aptamers for targeted siRNA delivery.

    John is a Section Editor for BMC Biotechnology.

  • Yun-Bo Shi

    Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, USA

    Yun-Bo is a senior investigator and the head of Section on Molecular Morphogenesis, Program on Cell Regulation and Metabolism, Eunice Kennedy Shriver National Institute Child Health and Human Development (NICHD), NIH, Bethesda, MD. He received his B. S. degree from the Department of Chemistry, Wuhan University, China, in 1982 and his Ph.D. degree from the Department of Chemistry, University of California, Berkeley, CA, in 1988. After postdoctoral training at the Carnegie Institution, Baltimore, MD, Yun-Bo established his own research group within the intramural research program of NICHD, NIH, in 1992.

    Yun-Bo is interested in the molecular basis of thyroid hormone regulation of vertebrate development and uses Xenopus metamorphosis as a model system. He has published over 120 research papers and 50 reviews/book chapters, edited two books and written a monograph on amphibian metamorphosis. He has received the 2009 NIH APAO (Asian & Pacific Islander American Organization) Award for outstanding accomplishments in biomedical research and the 2008 Van Meter Award by the American Thyroid Association, which honors an investigator who has made outstanding contributions to research on the thyroid gland. In 2012, Yun-Bo was elected as a Fellow of the American Association for the Advancement of Science. He has also served on many domestic and international grant review panels, including NIH study sections, and organized a number of international symposia.

    Yun-Bo was an Editor of Cell Research from 2007 to 2010 and is currently the Editor-in-Chief of Cell & Bioscience and a board member of several journals including Thyroid and Journal of Biological Chemistry.

Neuroscience, Neurology and Psychiatry

  • Guojun Bu

    Mayo Clinic, USA

    Guojun is a Professor of Neuroscience at the Mayo Clinic. His primary research interest is to understand why APOE4 is a strong risk factor for Alzheimer’s disease and how this pathway can be targeted for therapy. Guojun received his undergraduate degree from Beijing Normal University and his Ph.D. degree from Virginia Tech. He completed his postdoctoral training at Washington University and served as a Professor of Cell Biology and Neuroscience there until 2010 when he moved his research laboratory to Mayo Clinic. Guojun has been an organizer for the International Conference on Molecular Neurodegeneration and serves as Co-Editor-in-Chief for Molecular Neurodegeneration.

     

  • Amos Korczyn

    Tel-Aviv University, Israel

    Amos graduated from the Hebrew University–Hadassah Medical School in Jerusalem in 1966 (MD), where he also received an MSc degree in pharmacology (cum laude) in 1966. He trained in neurology at Beilinson Hospital and at the National Hospital for Nervous Diseases, Queen Square, London. He was the Chairman of the Department of Neurology at the Tel-Aviv Medical Center since 1981 until 2002.He was the Sieratzki Professor of Neurology at Tel-Aviv University from 1995 until 2011.

    Amos has a particular interest in movement disorders, neurodegenerative diseases and dementia. He has authored or co-authored over 600 articles in peer-reviewed journals, as well as chapters in books, with an H-index of 39. He is, or has been, an Editorial Board member of 15 international journals, and organized several neurological conferences, mainly in the field of dementia, Parkinson’s disease and other degenerative brain disorders, as well as CONy – the International Congress on Controversies in Neurology. He is an honorary member of the neurological societies of Israel, Serbia, Poland and Russia.

    Amos is on the Editorial Boards of BMC Neurology, BMC Medicine and Translational Neurodegeneration.

  • Robert Zivadinov

    University of Buffalo, USA

    Robert, is a professor of neurology with tenure at University of Buffalo, State University of New York (SUNY) and clinical professor of neurology at the Florida International University, College of Medicine. He is also the Director of the Buffalo Neuroimaging Analysis Center and the Director of Resident and Fellowship Research program at the Department of Neurology at University of Buffalo. He has staff privileges at the Jacobs Neurological Institute, Baird MS Research Center and Kaleida Health. Robert has acquired extensive research experience in multiple sclerosis. His accomplishments in this field include numerous awards from European and national neurological societies for his published articles, research studies and research fellowships. He has authored more than 200 publications, including print and online articles and 400 abstracts. His work has appeared in journals such as Neurology, Brain, Neuroimage, Annals of Neurology, Archives of Neurology, the Journal of Neurology, Neurosurgery and Psychiatry, Journal of Neurology, Multiple Sclerosis, Neuroepidemiology, BMC Med, PLoS One, J Neuroinflamm etc. He is currently pursuing research studies of quantitative magnetic resonance imaging findings and venous function in neurological disorders and aging, and therapeutic interventions including strategies towards assessing neuroprotective efforts in multiple sclerosis, but his current interests are also concentrated on genetic and neuroepidemiology fields of the same disease.

    Robert is on the Editorial Board of BMC Medicine.

Open data

  • John Wilbanks

    Sage Bionetworks

    John Wilbanks is Chief Commons Officer at Sage Bionetworks. He also serves as a senior advisor to the National Coordination Office and as a senior fellow at  FasterCures. With his Sage Bionetworks hat on, he is working on a “portable” approach to informed consent and testing it in a series of clinical research studies in which people take the data they can gather about their own health and donate it for computational analysis. With his NCO hat on, he works on issues related to federal priorities in big data and health IT, and at FasterCures he writes a series on open science. He also campaigns for public access to science through projects like the Access2Research petition, and is a co-author of the Panton Principles of Open Scientific Data. John has also worked at Harvard’s Berkman Center for Internet & Society, the World Wide Web Consortium, the US House of Representatives, Creative Commons (hosted at MIT’s Project on Mathematics and Computation), and the Ewing Marion Kauffman Foundation. In 2000 he started a bioinformatics company called Incellico, which is now part of Selventa. He studied philosophy at Tulane University.

  • Heather Piwowar

    ImpactStory

    Heather Piwowar is a cofounder of ImpactStory and a leading researcher in the area of research data availability and data reuse. She wrote one of the first papers to measure the citation benefit of publicly available research data and has studied patterns in public deposition of datasets, patterns of data reuse, and the impact of journal data sharing policies. Heather has a bachelor’s and master’s degree from MIT in electrical engineering, 10 years of experience as a software engineer in small companies, and a Ph.D. in Biomedical Informatics from the University of Pittsburgh. She is an frequent speaker on research data archiving, writes a well-respected research blog, and is active on twitter (@researchremix).

     

  • Cameron Neylon

    Public Library of Science

    Cameron Neylon is a biophysicist who has always worked in interdisciplinary areas and is an advocate of open research practice and improved data management. Along with his work in structural biology and biophysics, his research and writing focuses on the interface of web technology with science and the successful (and unsuccessful) application of generic and specially designed tools in the academic research environment. He is a co-author of the Panton Principles for Open Data in Science and writes regularly on the social, technical, and policy issues of open research at his blog.  In 2012 he joined PLoS as Advocacy Director.

     

  • Peter Murray-Rust

    University of Cambridge, UK

    Peter Murray-Rust is a Reader in Molecular Informatics at the University of Cambridge and Senior Research Fellow of Churchill College. His research interests have involved the automated analysis of data in scientific publications, creation of virtual communities (e.g. The Virtual School of Natural Sciences in the Globewide Network Academy) and the Semantic Web. With Henry Rzepa he has extended this to chemistry through the development of markup languages, especially Chemical Markup Language. He campaigns for Open Data, particularly in science, and is on the advisory board of the Open Knowledge Foundation and a co-author of the Panton Principles for Open Scientific Data.

     

  • Kaitlin Thaney

    Mozilla Science Lab

    Kaitlin Thaney is the director of the Mozilla Science Lab, a new open science initiative of the Mozilla Foundation. The Science Lab connects the open science community and empowers researchers, coders, funders and other partners to make research more like the web: open, collaborative and accessible. Kaitlin came to Mozilla from Digital Science, a technology company that works to make research more efficient through better use of software. She works closely with policymakers, charities and industry in a variety of roles, advising the UK government on digital technology, serving as a Director for DataKind UK, and acting as co-chair for the Strata Conference series in Europe on big data. Prior to Mozilla and Digital Science, Kaitlin managed the science program at Creative Commons, worked on education technology with MIT and Microsoft, and wrote for the Boston Globe. You can follow her at @kaythaney.

Plant Biology, Environmental Biology and Ecology

  • Julian Hibberd

     University of Cambridge, UK

    Julian is a plant scientist currently working at the University of Cambridge. He gained his first degree in 1991 and PhD in 1994, both at the University of Bangor.In 2008 he was named by Nature as one of “Five crop researchers who could change the world” for his research that is attempting to replace C3 carbon fixation in rice with C4 carbon fixation.This would greatly increase the efficiency of photosynthesis and create a rice cultivar with an increased yield. His research is interdisciplinary, including the use of molecular and physiological techniques through to bioinformatics.

     

     

  • Yvonne Buckley

    Trinity College Dublin, Ireland

    Yvonne completed her undergraduate degree in 1997 at the University of Oxford, and studied for her PhD with Mark Rees at Imperial College London. Yvonne then went on to become a Research Fellow at the University of Queensland, Australia and a visiting researcher, at CSIRO Ecosystem Sciences. She and her group are interested in uses ecological theory and synthesis to make decisions about the management of processes which threaten ecosystem function and biodiversity. In particular, she works on the population dynamics, dispersal, evolution and herbivore interactions of both native and invasive plants, developing models to address applied problems and provide practical solutions. Yvonne has recently taken up a position as Chair of Zoology at Trinity College Dublin, Ireland.

    Yvonne is an Editorial Board Member for Movement Ecology.

     

  • Rob Marrs

    University of Liverpool, UK

    Rob is currently the Bulley Professor of Applied Plant Biology within the University of Liverpool’s School of Environmental Sciences, and works in the Ecology and Marine Biology group. Rob is a conservation biologist, with broad ranging interests across many different ecosystems and investigating numerous environmental issues and solutions. He has worked in ecosystems from the sub-tundra through to tropical rain forests but his main passion is in semi-natural, cultural landscapes of the British uplands.

    His research has involved research covering structured surveys of vegetation communities, often at the national-scale; long-term, designed experiments designed to test the effects of applied interventions of plant and soil communities, and ecological modelling. Much of this work involves fairly complex statistical analysis. He has published over 200 papers covering both theoretical and practical research.

    Rob is an Editorial Board Member for Environmental Evidence, as well as a founding member of the board for the Collaboration for Environmental Evidence.

Public Health and Health Services Research

  • Michel Wensing

    Radbound University, Netherlands

    Michel is medical care researcher and professor of Implementation Science at Radboud University Nijmegen Medical Centre, the Netherlands. He is also affiliated with Heidelberg University Hospital, Department of General Practice and Health Services Research. With a background in the social sciences, he did a Ph.D. and an Habilitation in the medical sciences. His research aims to identify how healthcare practice and outcomes can be improved, particularly in primary care. He has been involved as coordinator or participant in many international studies concerning quality of primary care. He has (co-)authored about 250 scientific papers, including about 30 large trials of implementation strategies. He is co-editor of the book ‘Implementation of innovations’, which provides an evidence-based and comprehensive overview of the field. Since 2012, he has been Editor in Chief of the journal Implementation Science.

  • Omar Khan

    Jefferson Medical College & Christiana Care Health System, USA

    Omar is the Medical Director for the Center for Community Health, and the Eugene duPont Preventive Medicine & Rehabilitation Institute [www.christianacare.org/pmri], at the Christiana Care Health System. He is affiliated with the Dept. of Family & Community Medicine and serves as Director of the Global Health Track. He is trained in family medicine & in public health, with active interests in global health and medical education. He received his BA and MA from the University of Pennsylvania, medical degree and residency from the University of Vermont College of Medicine, and MHS in public health from the Johns Hopkins University School of Public Health.

    Omar’s experience includes working with USAID and serving as faculty at the Johns Hopkins School of Public Health and the University of Vermont. He is presently Clinical Assistant Professor, Depts. of Family Medicine at Jefferson Medical College, University of Pennsylvania & the University of Vermont. He serves as Chair of the Global Health Working Group for the Delaware Health Sciences Alliance [http://www.delawarehsa.org/education/global_health.html], Past-President of the Delaware Academy of Family Physicians, and Chair of the Science Board for the American Public Health Association (APHA).

    Omar on the Editorial boards of BMC Public Health and BMC International Health and Human Rights.

  • Martin McKee

    London School of Hygiene & Tropical Medicine, UK

    Martin is Professor of European Public Health at London School of Hygiene & Tropical Medicine (LSHTM) and a visiting professor at the Universities of Belgrade and Zagreb, the London School of Economics, and Taipei Medical University. He co-directs the European Centre on Health of Societies in Transition (ECOHOST) and is also research director of the European Observatory on Health Systems and Policies. He chairs the WHO’s European Advisory Committee on Health Research and the Global Health Advisory Committee of George Soros’ Open Society Foundations, and has previously been a trustee of the UK Public Health Association. He has published over 650 papers in peer-reviewed journals and is author or editor of almost 40 books. In 2005 Martin was made a Commander of the Order of the British Empire (CBE) by HM Queen Elizabeth II.

    Martin is on the Editorial Board of the Israel Journal of Health Policy ResearchPopulation Health Metrics and BMC International Health and Human Rights.

Translational Medicine

  • Samuel H H Chan

    Chang Gung Memorial Hospital, Taiwan

    Professor Samuel H.H. Chan received his PhD in Physiology from Indiana University in 1971 working on modulation of spinal motoneurons by the brain stem. Following postdoctoral training in Neurology at Mount Sinai School of Medicine in New York, he has held academic positions at University of Hong Kong (1973-1977), Indiana University (1977-1982), National University of Singapore (1982-1985), and National Yang-Ming University (1986-1998) in Taipei, Taiwan. In 1997, Professor Chan was appointed the National Chair Professor of Neuroscience, the highest honor bestowed by the Ministry of Education, Taiwan, and was recruited in 1998 to establish and direct a new Center for Neuroscience at the National Sun Yat-sen University in Kaohsiung, Taiwan, where he additionally served as Vice-President for Academic Affairs from 2002 to 2004. He was invited to his current position in 2009 as the Inaugural Director and Distinguished Chair Professor of a new state-of-the-art Center for Translational Research in Biomedical Sciences at Chang Gung Memorial Hospital-Kaohsiung Medical Center. As the Vice-Chairman of the Committee on Research and Development, Chang Gung Medical Foundation since 2012, he also oversees the planning and execution of research activities of the entire Chang Gung Memorial hospital system made up of 6 medical centers with a total of 10,000 beds.
    Professor Chan is recognized internationally for his distinguished contributions to central cardiovascular regulatory functions, particularly in translational research on brain death and neurogenic hypertension. He is the recipient of numerous prestigious awards and honors for his research accomplishments, including the Outstanding Commissioned Researcher Award, the highest honor conferred by the National Science Council, Taiwan. He was a member of the Commission on Autonomic Nervous System, IUPS; an inaugural Executive Committee Member of the International Society for Autonomic Neuroscience Research; a member of the Asia-Pacific Regional Committee, International Brain Research Organization (IBRO); a member of the IBRO Advisory Science Program Committee; President of the Pharmacological Society in Taiwan; President of the Neuroscience Society in Taiwan and Editor-in-Chief of the Journal of Biomedical Science. He is currently President of the Asia Pacific Federation of Pharmacologists, and Series Editor of the monograph series Translational Research in Biomedicine published by Karger AB in Switzerland.

  • Munir Pirmohamed

    University of Liverpool, UK

    Munir Pirmohamed is currently David Weatherall Chair in Medicine at the University of Liverpool, and a Consultant Physician at the Royal Liverpool University Hospital.  He also holds the only NHS Chair of Pharmacogenetics in the UK, and is Deputy Director of the M.R.C. Centre for Drug Safety Sciences, and Director of the Wolfson Centre for Personalised Medicine. He is also an inaugural NIHR Senior Investigator, and Fellow of the Academy of Medical Sciences in the UK. He has authored over 320 peer-reviewed publications.

    His  research focuses on individual variability in drug response, both safety and efficacy, with a view to evaluating the mechanisms, and identifying strategies to personalise healthcare in order to optimise drug efficacy and minimise toxicity. The work spans the whole spectrum from discovery to implementation with laboratory based studies being linked translationally to patient studies, with the aim being to develop the evidence base that can move discoveries from the lab to the clinic, and from clinic to application.  Professor Pirmohamed has received a number of honours including most recently, the William Withering Medal from the Royal College of Physicians and the IPIT award for Public Service from the University of North Carolina in the US.